dipyridamole has been researched along with Hemorrhagic Shock in 6 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dipyridamole is a platelet inhibitor that promotes anti-inflammatory effects." | 5.38 | Treatment with dipyridamole improves cardiac function and prevent injury in a rat model of hemorrhage. ( Arafah, MM; Soliman, MM, 2012) |
| "Dipyridamole is a platelet inhibitor that promotes anti-inflammatory effects." | 1.38 | Treatment with dipyridamole improves cardiac function and prevent injury in a rat model of hemorrhage. ( Arafah, MM; Soliman, MM, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Soliman, MM | 1 |
| Arafah, MM | 1 |
| Kaseno, S | 1 |
| Gotoh, Y | 1 |
| Furukawa, K | 2 |
| Kubota, M | 1 |
| Olinde, JG | 1 |
| Zibari, GB | 1 |
| Brown, MF | 1 |
| Howell, JG | 1 |
| Akgür, FM | 1 |
| Granger, DN | 1 |
| McDonald, JC | 1 |
| Saggau, W | 1 |
| Bleyl, U | 1 |
| Brückner, UB | 1 |
| Klöss, T | 1 |
| Leinberger, H | 1 |
| Metzker, M | 1 |
| Schmier, J | 1 |
| Jones, CE | 1 |
| Bethea, HL | 1 |
| Smith, EE | 1 |
| Crowell, JW | 1 |
6 other studies available for dipyridamole and Hemorrhagic Shock
| Article | Year |
|---|---|
Treatment with dipyridamole improves cardiac function and prevent injury in a rat model of hemorrhage.
Topics: Animals; Blood Pressure; Dipyridamole; Disease Models, Animal; Heart; Hemorrhage; Hydrogen-Ion Conce | 2012 |
[The effect of coronary vasodilator on cardiac function in hemorrhagic shock].
Topics: Animals; Dipyridamole; Dogs; Myocardial Contraction; Shock, Hemorrhagic | 1984 |
Persantine attenuates hemorrhagic shock-induced P-selectin expression.
Topics: Adenosine; Animals; Colon; Dipyridamole; Disease Models, Animal; Drug Evaluation, Preclinical; Intes | 2000 |
Hemodynamic parameters and drug action in shock.
Topics: Animals; Blood Pressure; Cardiac Output; Dipyridamole; Dogs; Dose-Response Relationship, Drug; Heart | 1977 |
[Pulmonary hemodynamics, coagulation and morphological changes in the lung after thrombocyte aggregation inhibition and intravasal coagulation in experimental trauma and hemorrhagic shock].
Topics: Airway Resistance; Animals; Aspirin; Dipyridamole; Dogs; Hemodynamics; Lung; Platelet Aggregation; S | 1976 |
Effect of a coronary vasodilator on the development of irreversible hemorrhagic shock.
Topics: Animals; Arteries; Blood Pressure; Blood Volume; Coronary Vessels; Dipyridamole; Disease Models, Ani | 1970 |